Waters Corporation: Microbiology & Mass Spec Expansion & Other Critical Growth Levers! 

Waters Corporation reported a robust financial performance for the second quarter of 2025, showcasing strong sales growth, enhanced product innovation, and strategic expansion into high-growth areas. The company achieved a 9% sales increase as reported, and 8% on a constant currency basis. This success was fueled by growth in their LC and mass spectrometry portfolios, and double-digit growth in recurring revenue streams such as services and consumable chemistry.